Original
Discordance of positive immunohistochemical results among different primary HER2 antibodies used in breast cancer: A comparison between Histofine® HER2 Kit (MONO) SV2-61γ antibody and Ventana I-VIEW PATHWAY™ HER2 4B5 antibody
Discordancia de los resultados inmunohistoquímicos positivos entre los diferentes anticuerpos primarios HER2 utilizados en el cáncer de mama: comparación entre el anticuerpo Histofine® HER2 Kit (MONO) SV2-61γ y el anticuerpo Ventana I-VIEW PATHWAY™ HER2 4B5
Juntendo University Graduate School of Medicine, Department of Human Pathology, Tokyo, Japan
Read
114
Timeswas read the article
13
Total PDF
101
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2023 November | 3 | 0 | 3 |
| 2023 August | 1 | 2 | 3 |
| 2023 April | 0 | 2 | 2 |
| 2023 March | 1 | 0 | 1 |
| 2023 February | 84 | 2 | 86 |
| 2023 January | 3 | 2 | 5 |
| 2022 December | 1 | 0 | 1 |
| 2022 November | 1 | 0 | 1 |
| 2022 October | 6 | 3 | 9 |
| 2022 September | 1 | 2 | 3 |
